Enterococcus faecium | |
---|---|
Scientific classification | |
Kingdom: | Bacteria |
Phylum: | Firmicutes |
Class: | Bacilli |
Order: | Lactobacillales |
Family: | Enterococcaceae |
Genus: | Enterococcus |
Species: | E. faecium |
Binomial name | |
Enterococcus faecium (Orla-Jensen 1919) Schleifer & Kilpper-Bälz 1984 |
Enterococcus faecium is a Gram-positive, alpha-hemolytic or nonhemolytic bacterium in the genus Enterococcus. It can be commensal (innocuous, coexisting organism) in the human intestine, but it may also be pathogenic, causing diseases such as neonatal meningitis or endocarditis.
Vancomycin-resistant E. faecium is often referred to as VRE.
Some strains of E. faecium are used as probiotics in both animals and humans.
Genomes listed below are from the Integrated Microbial Genomes website.
The 22 sequenced Enterococcus faecium genomes
Linezolid or daptomycin is used to treat VRE infections. The streptogramins, such as quinupristin/dalfopristin, may also be used for VREs. VRE can be successfully treated with sultamicillin.
Sadowy, E; Luczkiewicz, A (14 March 2014). "Drug-resistant and hospital-associated Enterococcus faecium from wastewater, riverine estuary and anthropogenically impacted marine catchment basin.". BMC microbiology. 14: 66. doi:10.1186/1471-2180-14-66. PMID 24629030.